LivaNova PLC
- LIVN
- NASDAQ
- Medical devices
- Cardiopulmonary/Heart-Lung Devices
- Neuromodulation (VNS)
$78.14
Today +0.72%Quote Oct 19, 2026, 08:00 PM UTC
−0.27%over the last month
Max drawdown −4.8%From 1-month high −1.2%3 months −2.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About LivaNova
LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments.
Where the money comes from
Q2 2026 revenue $388.5M
- Cardiopulmonary Segment$221.6M57.0%
- Neuromodulation Segment$166.9M43.0%
Sector
Healthcare
Industry
Medical devices
Exchange
NASDAQ
Employees
3,300
Founded
1987
Market value
$4.29B
Quote Oct 19
Floor
$77.43
0.9% below price
Resistance
$79.52
1.8% above price
Price vs analyst targets
15 analysts
Lowest target
$85.00Highest target
$105.00
$85.00Highest target
$105.00
- Price $78.14
- Average target $93.33
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 19% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LIVNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free